237 related articles for article (PubMed ID: 35788345)
1. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
2. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
6. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
7. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
Clin Chim Acta; 2024 May; 560():119732. PubMed ID: 38772522
[TBL] [Abstract][Full Text] [Related]
9. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
10. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
[TBL] [Abstract][Full Text] [Related]
11. Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses.
Lin Y; Lau HC; Liu Y; Kang X; Wang Y; Ting NL; Kwong TN; Han J; Liu W; Liu C; She J; Wong SH; Sung JJ; Yu J
Gastroenterology; 2022 Oct; 163(4):908-921. PubMed ID: 35724733
[TBL] [Abstract][Full Text] [Related]
12. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
[TBL] [Abstract][Full Text] [Related]
14. A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer.
Wang Q; Li L; Xu R
Sci Rep; 2018 Apr; 8(1):6225. PubMed ID: 29670137
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
Thomas AM; Manghi P; Asnicar F; Pasolli E; Armanini F; Zolfo M; Beghini F; Manara S; Karcher N; Pozzi C; Gandini S; Serrano D; Tarallo S; Francavilla A; Gallo G; Trompetto M; Ferrero G; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Wirbel J; Schrotz-King P; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G; Cordero F; Dias-Neto E; Setubal JC; Tett A; Pardini B; Rescigno M; Waldron L; Naccarati A; Segata N
Nat Med; 2019 Apr; 25(4):667-678. PubMed ID: 30936548
[TBL] [Abstract][Full Text] [Related]
16. Integrating clinical and cross-cohort metagenomic features: a stable and non-invasive colorectal cancer and adenoma diagnostic model.
Zhou D; Chen Y; Wang Z; Zhu S; Zhang L; Song J; Bai T; Hou X
Front Mol Biosci; 2023; 10():1298679. PubMed ID: 38455360
[No Abstract] [Full Text] [Related]
17. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer.
Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N
Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
20. Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.
Zhao L; Wang C; Peng S; Zhu X; Zhang Z; Zhao Y; Zhang J; Zhao G; Zhang T; Heng X; Zhang L
J Transl Med; 2022 Oct; 20(1):459. PubMed ID: 36209079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
